famotidine has been researched along with Digestive System Diseases in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Digestive System Diseases: Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Degtiareva, II | 1 |
| Semeunović, S | 1 |
| Petrović, S | 1 |
| Gaĭsenko, AV | 1 |
| Kharchenko, NV | 1 |
| Egorova, IT | 1 |
1 trial available for famotidine and Digestive System Diseases
| Article | Year |
|---|---|
[The efficacy of using letsedil for treating patients with digestive organ diseases].
Topics: Aluminum Hydroxide; Antacids; Benzilates; Benzocaine; Choline; Cimetidine; Digestive System Diseases | 1996 |